Lista de obras -

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial

artículo científico publicado en 2017

Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2

artículo científico publicado en 2020

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

artículo científico publicado en 2017

Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial

artículo científico publicado en 2017

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

article

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

scientific article published on 02 September 2013

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

artículo científico

Effects of Serelaxin in Patients with Acute Heart Failure

scientific article published on 01 August 2019

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial

artículo científico publicado en 2017

Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial

artículo científico publicado en 2019

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment

artículo científico publicado en 2017

Rationale and design of the multicentre, randomized, double‐blind, placebo‐controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) ⬇️

artículo científico publicado el 30 de noviembre de 2010

Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial

artículo científico publicado en 2020

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study

artículo científico publicado en 2017

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.

artículo científico publicado en 2018

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.

artículo científico publicado en 2015

Lista de obras de

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial

Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

Effects of Serelaxin in Patients with Acute Heart Failure

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial

Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment

Rationale and design of the multicentre, randomized, double‐blind, placebo‐controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) ⬇️

Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.

The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.